Heartflow (HTFL) EBITDA Margin (2024 - 2025)
Heartflow's (HTFL) quarterly EBITDA Margin came in at 36.13% in Q4 2025, up 978.0% year-on-year from 3.35% in Q4 2024, and down 10.73% quarter-over-quarter from 32.63% in Q3 2025.
Heartflow (HTFL) EBITDA Margin (2024 - 2025) Analysis & Trends
Heartflow's EBITDA Margin history runs 2 years deep, the most recent figure standing at 36.13% for Q4 2025.
- On a quarterly basis, EBITDA Margin rose 978.0% year-over-year to 36.13% in Q4 2025; TTM through Dec 2025 was 36.03%, a N/A change from a year earlier, with the FY2025 full-year figure at 36.39%, up 1227.0% from the prior year.
- EBITDA Margin eased to 36.13% in Q4 2025 per HTFL's latest filing, from 32.63% in the prior quarter.
- Across five years, EBITDA Margin topped out at 31.58% in Q2 2025 and bottomed at 45.91% in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 29.34 Bn | 22.03 Bn | 662.02 Mn | 30.93% |
| 2 | BrightSpring Health Services | 13.49 Bn | 12.59 Bn | 482.22 Mn | 3.36% |
| 3 | Healthequity | 7.96 Bn | 7.70 Bn | 256.31 Mn | 29.03% |
| 4 | 10x Genomics | 6.17 Bn | 5.63 Bn | 106.18 Mn | -11.30% |
| 5 | Hinge Health | 6.02 Bn | 5.70 Bn | 154.23 Mn | 17.59% |
| 6 | MiniMed | 4.19 Bn | 3.89 Bn | 480.00 Mn | -11.11% |
| 7 | Waystar Holding | 4.14 Bn | 4.07 Bn | 216.84 Mn | 25.64% |
| 8 | Doximity | 3.82 Bn | 3.08 Bn | 125.97 Mn | 17.08% |
| 9 | Privia Health | 3.10 Bn | 2.73 Bn | - | 1.23% |
| 10 | Heartflow | 906.97 Mn | 730.19 Mn | 39.06 Mn | -36.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -36.13% |
| Sep 30, 2025 | -32.63% |
| Jun 30, 2025 | -31.58% |
| Dec 31, 2024 | -45.91% |
| Sep 30, 2024 | -45.33% |
| Jun 30, 2024 | -45.65% |